NeuroscienceMolecular TherapyPeer-reviewed
Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma
Alejandra Bosco, Sarah Anderson, Kevin Breen…·Monica L. Vetter
This study shows that targeting complement C3 with gene therapy reduces neurodegeneration in glaucoma by protecting retinal ganglion cells.
110 citationstop 1%